|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/551 | |
| A61K 31/423 | |||
| C07D 413/14 |
| (11) | Patento numeris | 3134092 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15782608.2 |
| Europos patento paraiškos padavimo data | 2015-04-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/026060 |
| Data | 2015-04-16 |
| (87) | Numeris | WO 2015/164160 |
| Data | 2015-10-29 |
| (30) | Numeris | Data | Šalis |
| 201461981889 P | 2014-04-21 | US |
| (72) |
MCNEVIN, Michael, US
LOHANI, Sachin, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST |
| PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST |